Novel Oral Agent Effective in Teens With Atopic Dermatitis Novel Oral Agent Effective in Teens With Atopic Dermatitis

The investigational drug abrocitinib, shown in a recent phase 3 trial to be effective for moderate to severe atopic dermatitis in adults 18 years and older, is also safe and effective in teens.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news